
Medicare Closes One Regulatory Gap But Opens Another
The federal government’s new plan to rescue medical devices from regulatory limbo comes with a hidden catch that could leave many innovators behind.
Discover the newest research about AI innovations in 💼 Health Entrepreneurship.

The federal government’s new plan to rescue medical devices from regulatory limbo comes with a hidden catch that could leave many innovators behind.

When commercial software cannot keep pace with clinical reality, health systems are forced to become software developers.

The rapid acquisition of a two-year-old voice tech startup signals a major shift in how pharmaceutical companies recruit patients.

A massive bet on automated healthcare administration is paying off for insurers, but it raises difficult questions about who really wins when algorithms make medical decisions.

Federal officials are quietly clearing the runway for clinical AI, but their hands-off approach is triggering a chaotic state-level rebellion.

Pharma is moving from AI-driven drug discovery to AI-driven trial simulation to fix a costly ninety percent failure rate.

A young startup is spending hundreds of millions to prove that artificial intelligence can salvage stalled drug pipelines.

Federal regulators are closing the fast track to extra Medicare funding, forcing medical device makers to prove real clinical value rather than relying on a prestigious FDA label.

A massive new capital injection proves that venture capital is bypassing traditional doctors to sell health tracking directly to anxious consumers.

Hospitals are losing millions because surgeons are terrible at paperwork, but the solution is not another dictation tool—it is the video feed itself.